GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (NSE:CONCORDBIO) » Definitions » YoY Rev. per Sh. Growth

Concord Biotech (NSE:CONCORDBIO) YoY Rev. per Sh. Growth : 34.66% (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Concord Biotech's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 was 34.66%.

Concord Biotech's Revenue per Share for the three months ended in Mar. 2025 was ₹41.04.

Concord Biotech YoY Rev. per Sh. Growth Historical Data

The historical data trend for Concord Biotech's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech YoY Rev. per Sh. Growth Chart

Concord Biotech Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial 21.25 17.28 17.25 22.43 18.00

Concord Biotech Quarterly Data
Mar20 Mar21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.52 10.84 18.28 1.53 34.66

Concord Biotech YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Concord Biotech's YoY Rev. per Sh. Growth for the fiscal year that ended in Mar. 2025 is calculated as:

YoY Rev. per Sh. Growth (A: Mar. 2025 )
=(Revenue per Share (A: Mar. 2025 )-Revenue per Share (A: Mar. 2024 ))/ | Revenue per Share (A: Mar. 2024 ) |
=(114.699-97.204)/ | 97.204 |
=18.00 %

Concord Biotech's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY Rev. per Sh. Growth (Q: Mar. 2025 )
=(Revenue per Share (Q: Mar. 2025 )-Revenue per Share (Q: Mar. 2024 )) / | Revenue per Share (Q: Mar. 2024 )) |
=(41.044-30.479)/ | 30.479 |
=34.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Concord Biotech YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Concord Biotech's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (NSE:CONCORDBIO) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
BOM:544009 BOM:544292 BOM:543434 BOM:540701 BOM:531349 NSE:ZOTA BOM:532067 BOM:500259 BOM:540679 BOM:524717 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
543960:India
Address
Iscon Cross Road, S.G. Highway, B-1601-1602, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015
Website
https://www.concordbiotech.com
Concord Biotech Ltd is a research and development-driven biopharma company that manufactures Active Pharmaceutical Ingredients (API) through fermentation and semi-synthetic process and finished formulations. It is mainly engaged in the business of manufacturing and trading in pharmaceutical products.

Concord Biotech Headlines

No Headlines